Docket Number:13A-931201
Inventor:Hung Li, Yin-Jing Lee
IP Status:Issued US7,645,447B2
Abstract:
This invention relates to induction of autologous stem cells to provide a powerful source for all types of cell regeneration. It would be a great advantage in therapy of retinal ischemic degenerative diseases that are caused by retinal occlusions and diabetic retinopathy. We hope that this application may provide a long-term restoration of normal retinal function and help those people suffered from blindness.
Fields of Application:
Retinal degenerative diseases caused by ischemia. Such as retinal artery occlusion, retinal vein occlusion, and diabetic retinopathy etc.
Advantages when compared to the existing technologies:
Currently there isn't any effective therapy method could cure these diseases.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
